Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Burn scars heal abnormally and more research is needed to find better treatments.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Melatonin affects cashmere growth in goats by influencing stem cell and certain signaling pathways.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Scarless healing is complex and influenced by genetics and environment, while better understanding could improve scar treatment.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

New therapies are being developed that target integrin pathways to treat various diseases.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

The drug combination was safe and showed promise in treating advanced tumors.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Ganoderma lucidum extract may help treat stress-related hair loss.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

Burn scars form abnormally due to changes in wound healing, and more research is needed to improve treatments.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Early development of hair, teeth, and glands involves specific signaling pathways and cellular interactions.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.